Intravitreal ranibizumab for peripapillary neovascular membrane associated to papiledema due to idiopathic intracranial hypertension: a case report
DOI:
https://doi.org/10.17533/udea.iatreia.15253Keywords:
Intravitreal Injections, Papilledema, Pseudotumor CerebriAbstract
Peripapillary neovascular membrane is a rare complication of chronic papiledema. When the latter is due to idiopathic intracranial hypertension, neovascularization is even rarer. Because of this low occurrence, it is difficult to design studies to define the most appropriate treatment. We report the case of a woman who developed papiledema by idiopathic intracranial hypertension with peripapillary neovascular membrane, and who was successfully treated with intravitreal ranibizumab.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.